Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3136696 | 0.90 | NR3C1 (0.56) | NR3C1PGR | |
| SCHEMBL3144658 | 0.89 | NR3C1 (0.74) | NR3C1PGR | |
| SCHEMBL13380567 | 0.84 | NR3C1 (0.84) | NR3C1PGR | |
| SCHEMBL3152953 | 0.83 | NR3C1 (0.75) | NR3C1PGR | |
| SCHEMBL3149554 | 0.80 | NR3C1 (0.72) | NR3C1PGR | |
| SCHEMBL3144883 | 0.80 | NR3C1 (0.72) | NR3C1PGR | |
| SCHEMBL3149516 | 0.80 | NR3C1 (0.68) | NR3C1PGR | |
| SCHEMBL3141766 | 0.79 | NR3C1 (0.73) | NR3C1PGR | |
| SCHEMBL3140148 | 0.78 | NR3C1 (0.72) | NR3C1PGR | |
| SCHEMBL3145643 | 0.78 | NR3C1 (0.70) | NR3C1PGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100080786-A1 | Phenyl or Pyridinyl Substituted Indazoles Derivatives | ASTRAZENECA AB (SE) | 2010-04-01 | — | — | US | disclosed |
| US-20100080786-A1 | Phenyl or Pyridinyl Substituted Indazoles Derivatives | ASTRAZENECA AB (SE) | 2010-04-01 | — | — | US | disclosed |
| US-20100080786-A1 | Phenyl or Pyridinyl Substituted Indazoles Derivatives | ASTRAZENECA AB (SE) | 2010-04-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100080786-A1 | Phenyl or Pyridinyl Substituted Indazoles Derivatives | CYP3A5, CYP3A43, ABCB1 | NR3C1 2328/4885PGR 322/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.